CompletedNot Applicable

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT

187 participantsStarted 2010-05-21

Plain-language summary

In this case-only study, the investigators try to define a novel staging parameter, the Primary Tumor Burden Score (PTBS).

Who can participate

Age range40 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Neoadjuvant chemoradiotherapy and surgical resection of esophageal squamous cell carcinoma Exclusion Criteria: * Patients receiving neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma without surgical resection

What they're measuring

Five-year survival of patients

Timeframe: From surgery to the end of follow-up(at least 5 years later)

Trial details

NCT IDNCT05839002

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-01

View on ClinicalTrials.gov More Neoplasm, Esophagus trials